Zborovsky Lieby, Kleebauer Leonardo, Seidel Maria, Kostenko Arseni, von Eckardstein Leonard, Gombert Frank Otto, Weston John, Süssmuth Roderich D
Institut für Organische Chemie, Technische Universität Berlin Straße des 17. Juni 124 10623 Berlin Germany
Gombert Pharma Research Solutions (GPRS) Dornacherstrasse 120 CH 4053 Basel Switzerland.
Chem Sci. 2021 Oct 19;12(43):14606-14617. doi: 10.1039/d1sc04019g. eCollection 2021 Nov 10.
The worrisome development and spread of multidrug-resistant bacteria demands new antibacterial agents with strong bioactivities particularly against Gram-negative bacteria. Albicidins were recently structurally characterized as highly active antibacterial natural products from the bacterium . Albicidin, which effectively targets the bacterial DNA-gyrase, is a lipophilic hexapeptide mostly consisting of amino benzoic acid units and only one α-amino acid. In this study, we report on the design and synthesis of new albicidins, containing N-atoms on each of the 5 different phenyl rings. We systematically introduced N-atoms into the aromatic backbone to monitor intramolecular H-bonds and for one derivative correlated them with a significant enhancement of the antibacterial activity and activity spectrum, particularly also towards Gram-positive bacteria. In parallel we conducted DFT calculations to find the most stable conformation of each derivative. A drastic angle-change was observed for the lead compound and shows a preferred planarity through H-bonding with the introduced N-atom at the D-fragment of albicidin. Finally, we went to the next level and conducted the first experiments with an albicidin analogue. Our lead compound was evaluated in two different mouse experiments: In the first we show a promising PK profile and the absence of toxicity and in the second very good efficiency and reduction of the bacterial titre in an infection model with FQ-resistant clinically relevant strains. These results qualify albicidins as active antibacterial substances with the potential to be developed as a drug for treatment of infections caused by Gram-negative and Gram-positive bacteria.
多重耐药细菌令人担忧的发展和传播需要具有强大生物活性的新型抗菌剂,尤其是针对革兰氏阴性菌的抗菌剂。最近,杀白蛋白被从结构上表征为来自该细菌的高活性抗菌天然产物。杀白蛋白有效靶向细菌DNA旋转酶,是一种亲脂性六肽,主要由氨基苯甲酸单元组成,仅含一个α-氨基酸。在本研究中,我们报告了新型杀白蛋白的设计与合成,这些新型杀白蛋白在5个不同的苯环上均含有氮原子。我们系统地将氮原子引入芳香主链,以监测分子内氢键,并针对一种衍生物将其与抗菌活性和活性谱的显著增强相关联,特别是对革兰氏阳性菌的活性增强。同时,我们进行了密度泛函理论(DFT)计算,以找到每种衍生物最稳定的构象。观察到先导化合物有剧烈的角度变化,并且通过与杀白蛋白D片段上引入的氮原子形成氢键显示出优选的平面性。最后,我们更进一步,用一种杀白蛋白类似物进行了首次实验。我们的先导化合物在两项不同的小鼠实验中进行了评估:在第一项实验中,我们展示了有前景的药代动力学特征且无毒性,在第二项实验中,在由耐氟喹诺酮类临床相关菌株引起的感染模型中显示出非常好的疗效和细菌滴度的降低。这些结果使杀白蛋白成为有活性的抗菌物质,有潜力被开发为治疗由革兰氏阴性菌和革兰氏阳性菌引起的感染的药物。